JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, H.
Right arrow Articles by Erice, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, H.
Right arrow Articles by Erice, S.
Related Collections
Right arrow Pain
Right arrow Pharmacology

Anesth Analg 2003;96:1409-1412
© 2003 International Anesthesia Research Society

PAIN MEDICINE

The Effect of Clonidine on Gastrointestinal Side Effects Associated with Ultra-Rapid Opioid Detoxification

Hong Ma, PhD MD*, Jun Tang, MD*, Paul F. White, PhD MD, FANCZA*, Ronald H. Wender, MD{dagger}, Thomas Leverone, MD{ddagger}, Rayond Quon{dagger}, Scott Pearce, MD{dagger}, Franklin Chiao{dagger}, and Susan Erice, RN{ddagger}

*Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas, Texas; Department of Anesthesiology, {dagger}Cedars-Sinai Medical Center; and {ddagger}Centinela Hospital Medical Center, Los Angeles, California

Address correspondence to Dr. Paul F. White, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, F2.208, Dallas, TX 75390-9068. Address e-mail to paul.white{at}utsouthwestern.edu

IMPLICATIONS: Clonidine, an {alpha}2-adrenergic agonist, is used to minimize withdrawal symptoms related to ultra-rapid opioid detoxification procedures. These preliminary data suggest that clonidine possesses dose-related antidiarrheal activity.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
P. Kienbaum, J. Peters, N. Scherbaum, P. F. White, and R. H. Wender
Convincing Effects of Clonidine on Neurohumoral Withdrawal Symptoms During Antagonist-Supported Detoxification of Opioid Addicts * Response
Anesth. Analg., November 1, 2003; 97(5): 1547 - 1548.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2003 by the International Anesthesia Research Society.